Hormone & Metabolic Testing

Comprehensive hormone and metabolic blood panels assessing sex hormones (testosterone, oestrogen, progesterone, DHEA-S), thyroid function, cortisol, insulin resistance markers, and key metabolic biomarkers. Results are interpreted clinically to identify imbalances underlying fatigue, weight changes, cognitive decline, and accelerated ageing. Foundational to any personalised longevity programme for Perth adults.

Hormone and metabolic testing at Optima Longevity in Perth, WA, provides the diagnostic foundation for any personalised longevity and healthspan optimisation programme. The clinic's panels assess the full spectrum of endocrine markers relevant to biological ageing: sex hormones including total and free testosterone, oestradiol, progesterone, DHEA-S, and sex hormone binding globulin (SHBG) — which collectively govern energy, libido, body composition, bone density, mood, and cognitive function and decline progressively in both men and women from the mid-30s onward; thyroid function markers including TSH, free T3, free T4, and reverse T3, as subclinical thyroid dysfunction is one of the most frequently missed causes of fatigue, weight gain, and cognitive slowing in the Perth and broader Australian adult population; adrenal markers including morning cortisol and DHEA-S as indices of HPA axis function and adrenal reserve — relevant to stress resilience and chronic fatigue presentations that are common in Perth's high-output professional demographic; and fasting insulin and HOMA-IR as early-warning biomarkers of insulin resistance, a metabolic state that precedes type 2 diabetes by years to decades and substantially accelerates cardiovascular, cognitive, and cellular ageing. Comprehensive panels also cover hsCRP for chronic low-grade inflammation, homocysteine as a vascular and methylation marker, ferritin as an index of iron status, and vitamin D (25-OH). In Perth and Western Australia, hormonal imbalances — particularly low testosterone in men and oestrogen dysregulation in women approaching perimenopause — are among the most common reversible contributors to declining vitality and accelerated biological ageing in the 40–65 age bracket. Results are interpreted in clinical context, with the goal of optimised function rather than merely avoiding disease, and are used to guide therapeutic interventions including nutrient and hormone optimisation protocols.